MSCI is expanding its partnership with Google Cloud to utilize generative AI for investment advisory purposes, aiming to provide investors with enhanced decision-making capabilities, deep data-driven insights, and accelerated portfolio implementation in areas such as risk signals, conversational AI, and climate generative AI.
An AI-generated COVID drug enters clinical trials, GM and Google strengthen their AI partnership, and Israel unveils an advanced AI-powered surveillance plane, among other AI technology advancements.
Imbue, a woman-led AI research startup, has raised $200 million in a Series B funding round led by the Astera Institute, valuing the company at over $1 billion, but it could be years before it reveals a product. Imbue's focus is on developing AI "agents" that can simulate human decision-making to complete complex tasks, and it has access to 10,000 Nvidia H100 GPUs to build these agents. The startup is still in the early stages and has not yet released a demo of its agents.
Morgan Stanley has launched its generative AI assistant, based on OpenAI's GPT-4, for all financial advisors, aiming to revolutionize client interactions and increase efficiency.
